TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

被引：772

作者：

Yang, Li ^{[1
]}

Pang, Yanli ^{[1
]}

Moses, Harold L. ^{[2
]}

机构：

[1] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20876 USA

[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA

来源：

TRENDS IN IMMUNOLOGY | 2010年 / 31卷 / 06期

关键词：

GROWTH-FACTOR-BETA; NF-KAPPA-B; T-CELLS; MYELOID CELLS; COLON-CANCER; PROMOTE METASTASIS; LUNG METASTASIS; BREAST-CANCER; IN-VIVO; INFLAMMATION;

D O I：

10.1016/j.it.2010.04.002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Transforming growth factor beta (TGF-beta) plays an important role in tumor initiation and progression, functioning as both a suppressor and a promoter. The mechanisms underlying this dual role of TGF-beta remain unclear. TGF-beta exerts systemic immune suppression and inhibits host immunosurveillance. Neutralizing TGF-beta enhances CD8+ T-cell- and NK-cell-mediated anti-tumor immune responses. It also increases neutrophil-attracting chemokines resulting in recruitment and activation of neutrophils with an antitumor phenotype. In addition to its systemic effects, TGF-beta regulates infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the tumor miwcroenvironment causing direct changes in tumor cells. Understanding TGF-beta regulation at the interface of tumor and host immunity should provide insights into developing effective TGF-beta antagonists and biomarkers for patient selection and efficacy of TGF-beta antagonist treatment.

引用

页码：220 / 227

页数：8

共 86 条

[1] A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis [J].

Adorno, Maddalena ;

Cordenonsi, Michelangelo ;

Montagner, Marco ;

Dupont, Sirio ;

Wong, Christine ;

Hann, Byron ;

Solari, Aldo ;

Bobisse, Sara ;

Rondina, Maria Beatrice ;

Guzzardo, Vincenza ;

Parenti, Anna R. ;

Rosato, Antonio ;

Bicciato, Silvio ;

Balmain, Allan ;

Piccolo, Stefano .

CELL, 2009, 137 (01) :87-98

[2] TGF-β signaling in cancer -: a double-edged sword [J].

Akhurst, RJ ;

Derynck, R .

TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51

[3]

Almand B, 2000, CLIN CANCER RES, V6, P1755

[4] Inhibition of TGFβ signaling in cancer therapy [J].

Arteaga, CL .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (01) :30-37

[5] Cancer - An inflammatory link [J].

Balkwill, F ;

Coussens, LM .

NATURE, 2004, 431 (7007) :405-406

[6] TH-17 cells in the circle of immunity and autoimmunity [J].

Bettelli, Estelle ;

Oukka, Mohamed ;

Kuchroo, Vijay K. .

NATURE IMMUNOLOGY, 2007, 8 (04) :345-350

[7] TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia [J].

Bhowmick, NA ;

Chytil, A ;

Plieth, D ;

Gorska, AE ;

Dumont, N ;

Shappell, S ;

Washington, MK ;

Neilson, EG ;

Moses, HL .

SCIENCE, 2004, 303 (5659) :848-851

[8] Transforming growth factor-β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment [J].

Bierie, Brian ;

Stover, Daniel G. ;

Chytil, Anna ;

Gorska, Agnieszka E. ;

Aakre, Mary ;

Forrester, Elizabeth ;

Yang, Li ;

Wagner, Kay-Uwe ;

Moses, Harold L. .

CANCER RESEARCH, 2008, 68 (06) :1809-1819

[9] TGFβ:: the molecular Jekyll and Hyde of cancer [J].

Bierie, Brian ;

Moses, Harold L. .

NATURE REVIEWS CANCER, 2006, 6 (07) :506-520

[10] Gain or loss of TGFβ signaling in mammary carcinoma cells can promote metastasis [J].

Bierie, Brian ;

Moses, Harold L. .

CELL CYCLE, 2009, 8 (20) :3319-3327

← 1 2 3 4 5 6 7 8 9 →